World J Clin Oncol; 13 (4), 2022

Non-small cell lung cancer (NSCLC) is a heterogeneous disease accounting for approximately 85% of all lung cancers. Only 17% of patients are diagnosed at an early stage. Treatment is multidisciplinary and radiotherapy plays a key role in all stages of the disease. More than 50% of patients with NSCLC are...

Texte intégral (lien principal)     Texte intégral (lien alternatif)    

This quick guide contains the key recommendations from the national clinical guideline for the treatment of brain metastases. The national clinical guideline for the treatment of brain metastases focuses on treatment, including clarification of the treatment modality to be used in each individual case. B...

Texte intégral (lien principal)     Texte intégral (lien alternatif)